Peptomyc receives a business grant from ACCIÓ
This second grant in 2 months further supports Peptomyc in its mission to bring novel Myc inhibitors closer to clinical use for cancer treatment.
Peptomyc succeeds in gaining first grant funding from the European Commission
This grant represents the first big step forward for the company as it looks for further funding from investors to bring its novel Myc inhibitors closer to clinical application in cancer.
VHIR´s Health Innovation Contest 2015: first place goes to Myc Inhibitory Peptide
Source: The Vall d´Hebron Institute of Oncology
[…]